CN Stock MarketDetailed Quotes

Hubei Goto Biopharm (300966)

Watchlist
  • 27.29
  • +0.08+0.29%
Market Closed May 14 15:00 CST
3.15BMarket Cap-44.16P/E (TTM)

Hubei Goto Biopharm (300966) Revenue Breakdown Overview

By Product

Currency:CNY
2025/FY
Stock NameRevenueRatio
Self birth548.18M90.43%
非自产58M9.57%

By Industry

Currency:CNY
2025/FY
Stock NameRevenueRatio
甾体药物原料制造606.18M100.00%

By Country/Region

Currency:CNY
2025/FY
Stock NameRevenueRatio
Territory381.67M62.96%
Overseas224.51M37.04%

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More